Nebenwirkungen · Thalidomide BMS (previously Thalidomide Celgene)
Thalidomide BMS 50 mg hard capsules · Abschnitt 4.8 · PDF-Seite 14
HOS-118568 · Präparat HOS-094839
Peripheral neuropathy Peripheral neuropathy is a very common, potentially severe, adverse reaction of treatment with thalidomide that may result in irreversible damage (see section 4.4). Peripheral neuropathy generally occurs following chronic use over a period of months. However, reports following relatively short- term use also exist. Incidence of neuropathy events leading to discontinuation, dose reduction or interruption increases with cumulative dose and duration of therapy. Symptoms may occur some time after thalidomide treatment has been stopped and may resolve slowly or not at all.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-01-22T16:42:00Z · SHA-256 537c04bf4162671fd0a63561bed97ea3a0b2ca75db8df09543c26a61de067575 · Passage 327785165e6c4b361c3ebbcfe38ab656c47c8f4bb0403daa3e2ac8c2d80c9342 · Zeichen 8979–9575 im Abschnitt